Why Are Patients Switching from Tenofovir Disoproxil Fumarate/Emtricitabine (Truvada) to Tenofovir Alafenamide/Emtricitabine (Descovy) for Pre-Exposure Prophylaxis?
Author(s) -
Alexa B. D’Angelo,
Drew A. Westmoreland,
Pedro B. Carneiro,
Jeremiah Johnson,
Christian Grov
Publication year - 2021
Publication title -
aids patient care and stds
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.504
H-Index - 85
eISSN - 1557-7449
pISSN - 1087-2914
DOI - 10.1089/apc.2021.0033
Subject(s) - emtricitabine , tenofovir alafenamide , pre exposure prophylaxis , medicine , tenofovir , family medicine , human immunodeficiency virus (hiv) , men who have sex with men , viral load , syphilis , antiretroviral therapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom